"Santhera Pharmaceuticals shares surge on Friday amidst exciting downstream targets and Duchenne drug development updates. Join Dr. Thomas Meier, CEO of Santhera Pharmaceuticals Holding Ltd., in a webinar to learn about the latest progress in their pipeline and downstream targets. Don't miss out on this opportunity to stay informed and ahead of the curve in the world of pharmaceuticals and finance."